Skip to main content
Quest Diagnostics

Mapping the Literature on the Impact of Gastrointestinal Multiplexed Pathogen Panels on Clinical and Healthcare Utilization Outcomes: A Scoping Review

Mapping the Literature on the Impact of Gastrointestinal Multiplexed Pathogen Panels on Clinical and Healthcare Utilization Outcomes: A Scoping Review

Authors: Babiker A, Babady NE, Mochon AB, Roberts AL, Shier KL, Jackson JN, Parrott JS

Citation: J Appl Lab Med. 2025 Dec 16:jfaf180. doi: 10.1093/jalm/jfaf180. Online ahead of print.

Specialties: Infectious disease

Related content

Publication
Utility and recommendations for the use of multiplex molecular gastrointestinal pathogen panels
Test FAQ
Diagnosis of Intestinal Parasites
Publication
Viral Pathogen Detection Using Multiplex Gastrointestinal Molecular Panels: The Pros and Cons of Viral Target Inclusion
Publication
Seroprevalence of Antibodies to Burkholderia pseudomallei in Mississippi Gulf Coast Residents, September 2023

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.